Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
Rheumatology (Oxford, England)|September 14, 2022
Comparative effectiveness of guselkumab in psoriatic arthritis: updates to a systematic literature review and network meta-analysisPhilip J Mease, Iain B McInnes, Lai-Shan Tam, et al.
JCI Insight|July 21, 2022
Proprotein convertase subtilisin/kexin type 9 is a psoriasis-susceptibility locus that is negatively related to IL36GAlexander Merleev, Antonio Ji-Xu, Atrin Toussi, et al.
Nature Reviews. Rheumatology|February 16, 2021
Consensus terminology for preclinical phases of psoriatic arthritis for use in research studies: results from a Delphi consensus studyLourdes M Perez-Chada, Rebecca H Haberman, Vinod Chandran, et al.
Rheumatology (Oxford, England)|December 5, 2021
Upadacitinib as monotherapy and in combination with non-biologic disease-modifying antirheumatic drugs for psoriatic arthritisPeter Nash, Pascal Richette, Laure Gossec, et al.
Scientific Reports|October 16, 2020
A site-specific map of the human plasma glycome and its age and gender-associated alterationsAlexander A Merleev, Dayoung Park, Yixuan Xie, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 23, 2014
Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosisGary L Norman, Chen-Yen Yang, Heather P Ostendorff, et al.
The Journal of Rheumatology|August 1, 2024
Breakout Session and Report Back: Collaboration of Rheumatologists and Dermatologists for the Care of Patients With Psoriatic DiseaseDaniela Kampel Stolnicki, Laura C Coates, Charlotte E Gollins, et al.
Rheumatology (Oxford, England)|April 12, 2021
Comparative effectiveness of guselkumab in psoriatic arthritis: results from systematic literature review and network meta-analysisPhilip J Mease, Iain B McInnes, Lai-Shan Tam, et al.
Arthritis and Rheumatism|December 4, 2010
Abatacept in the treatment of patients with psoriatic arthritis: results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trialPhilip Mease, Mark C Genovese, Geoffrey Gladstein, et al.
JCI Insight|February 24, 2025
SPP1hi macrophages, NKG7 T cells, CCL5hi fibroblasts, and IgM plasma cells are dominant features of necrobiosisStephanie T Le, Alina I Marusina, Alexander A Merleev, et al.
Pageof 14